scholarly article | Q13442814 |
P356 | DOI | 10.1007/PL00005026 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/pl00005026 |
P698 | PubMed publication ID | 9228188 |
P50 | author | G Olmos | Q67934319 |
P2093 | author name string | J A García-Sevilla | |
R Alemany | |||
P433 | issue | 1 | |
P921 | main subject | 2-imidazoline | Q419555 |
P304 | page(s) | 39-47 | |
P577 | publication date | 1997-07-01 | |
P1433 | published in | Naunyn-Schmiedeberg's Archives of Pharmacology | Q1468251 |
P1476 | title | Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes | |
P478 | volume | 356 |
Q53413619 | 90 years of monoamine oxidase: some progress and some confusion. |
Q41444993 | A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus |
Q43264170 | Activation of I(2)-imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors |
Q35027984 | Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands. |
Q88598558 | Change in the Binding of [11C]BU99008 to Imidazoline I2 Receptor Using Brain PET in Zucker Rats |
Q48404030 | Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: a selective ligand for imidazoline I2 receptors. |
Q41835100 | Characterization of the discriminable stimulus produced by 2-BFI: effects of imidazoline I(2)-site ligands, MAOIs, beta-carbolines, agmatine and ibogaine |
Q45851009 | Chronic treatment with selective I2-imidazoline receptor ligands decreases the content of pro-apoptotic markers in rat brain |
Q43670401 | Differential [(3)H]idazoxan and [(3)H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) binding to imidazoline I(2) receptors in human postmortem frontal cortex. |
Q48683741 | Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2-(4,5-dihydro-1H-imidazol-2-yl)-1- methyl-1H-indole), for the imidazoline₂ binding site. |
Q21090747 | Fast, non-competitive and reversible inhibition of NMDA-activated currents by 2-BFI confers neuroprotection |
Q28375258 | Hyperphagic effect of novel compounds with high affinity for imidazoline I(2) binding sites |
Q37294224 | Identification of an imidazoline binding protein: creatine kinase and an imidazoline-2 binding site |
Q48147582 | Immunodetection and subcellular distribution of imidazoline receptor proteins with three antibodies in mouse and human brains: Effects of treatments with I1- and I2-imidazoline drugs. |
Q46897079 | Investigation of antioxidant vitamins (A, E, C) and lipid peroxidation levels in rats injected N-(1,3-benzothiazol-2-yl)-N-(4,5-dihydro-1H-imidazol-2-yl) amine |
Q48330142 | Pharmacology and subcellular distribution of [3H]rilmenidine binding sites in rat brain. |
Q41984937 | Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study |
Q77676057 | [3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidney |
Search more.